ACAD's logo.
Ticker Symbol: ACAD

Acadia Pharmaceuticals Inc

$20.46 - 14-07-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001070494

Company Profile

acadia pharmaceuticals (nasdaq: acad) is a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in related central nervous system (cns) disorders. all of acadia's product candidates emanate from internal discoveries. we believe that they offer innovative therapeutic approaches that may provide significant advantages relative to current therapies. acadia’s history is rooted in science and strong leadership in cns research. our proprietary drug discovery platform has led to a portfolio of drug candidates with large unmet needs. since the beginning, we have been dedicated to discovering, developing and commercializing innovative therapies that improve the lives of patients suffering from such disorders. acadia is headquartered in san diego. the city represents the second largest biotechnology industry cluster in the united states, home to over 400 companies, as well as the salk institute for biological studies

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 3611 Valley Centre Dr Ste 300
CEO: Stephen Davis
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing


Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $22.16
Change: -$0.77 ( -3.36%)
Days Range: $21.97 - $23.29
Beta: 1.03
52wk. High: $33.99
52wk. Low: $13.73
Ytd. Change 35.84%
50 Day Moving Average: $23.96
200 Day Moving Average: $24.53
Shares Outstanding: 163730000


Market Cap: 362.8B
PE Ratio: -32.55
EPS (TTM): -0.6807


Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A